BSTZ News and Press, BlackRock Science and Technology Trust II of Beneficial Interest From 02/19/21

Looking at addressing a question that comes up frequently about if a closed-end fund is right for you. Just because you have a high income portfolio, doesn't mean you can't achieve growth too through reinvestment. While the general consensus is that a younger person is better off ...

BST has outperformed the Nasdaq over the past year, quarter and year to date. It pays monthly and yields 3.7%. BSTZ, its newer sister tech fund, is selling at a -9% discount to NAV. For further details see: BlackRock Science And Technology Trust: Monthly Dividend Payer O...

For those who think that CEF market prices can defy gravity like stocks such as GameStop in which value is in the eye of the beholder, I've got news for you. And for those Robinhood, Reddit or retail investors who may stumble upon this article as part of a research effort, understand ...

We share the remaining top pick ideas from our Marketplace contributors. There are a wide variety - including biotech, precious metals, dividend, and energy ideas. Later on this week we will share the public Google Sheet that will track the performance of these ideas in real-time....

BMEZ delivered solid results throughout 2020, helped by the healthcare sector overall. This fund doesn't just invest in your typical healthcare companies though and tilts towards smaller and private investments. These companies are ripe for significant growth, at the same time, BM...

BSTZ was the top-performing closed-end fund in 2020. Chances are 2021 might not be so spectacular, but that doesn't mean strong returns can't be achieved again. As we entered into 2021, pressure mounted against tech and sent shares of BSTZ on a dip. Magnifying this is the widening...

BCAT was launched several months ago on September 25th, 2020. Now that we have a few months of data to go off of, I wanted to check out the fund. The fund is interesting in how flexible it is, but quickly jumped to a premium valuation and has stayed there. For further detail...

For the second month in a row, equity CEFs on average posted positive returns, rising 3.78% on a NAV basis for December. While for the ninth month running, fixed income CEFs witnessed returns in the black (+1.89%). Eighteen percent of all CEFs traded at a premium to their NAV, wit...

Readers have shown interest in seeing some of my top holdings outside of my closed-end portfolio. I hold a total of 30 stocks in this portfolio that all have a track record of dividend growth over the years. This portfolio is smaller, and less focused on overall diversification - ...

Though I'm not nearly as optimistic about 2021 as most prognosticators, we still have to go through the ritual of giving our Top Picks for the year. Looking back over 2020, it really was a year for huge winners and huge losers.  There really was not a tide lifting all boats until...